Risk assessments often must consider exposures that vary over time or for which the exposure duration of concern differs from the available data, and a variety of extrapolation procedures have been devised accordingly. The present experiments explore the relationship(s) between exposure concentration (C) and time (t) to investigate procedures for assessing the risks of short-term solvent exposures. The first hypothesis tested was that the product of C ؋ t would produce a constant health effect (Haber's rule). The second hypothesis tested was that exposure conditions produce effects in proportion to the tissue concentrations created. Awake, adult, male Long-Evans (LE) rats were exposed to trichloroethylene (TCE) vapor in a head-only exposure chamber while pattern onset/offset visual evoked potentials (VEPs) were recorded. Exposure conditions were designed to provide C ؋ t products of 0 ppm/h (0 ppm for 4 h) or 4000 ppm/h created through four exposure scenarios: 1000 ppm for 4 h; 2000 ppm for 2 h; 3000 ppm for 1.3 h; or 4000 ppm for 1h (n ‫؍‬ 9 -10/concentration). The amplitude of the VEP frequency double component (F2) was decreased significantly by exposure; this decrease was related to C but not to t or to the C ؋ t product, indicating that Haber's rule did not hold. The mean amplitude (؎ SEM in V) of the F2 component in the control and treatment groups measured 4.4 ؎ 0.5 (0 ppm/4 h), 3.1 ؎ 0.5 (1000 ppm/4 h), 3.1 ؎ 0.4 (2000 ppm/2 h), 2.3 ؎ 0.3 (3000 ppm/1.3 h), and 1.9 ؎ 0.4 (4000 ppm/1 h). A physiologically based pharmacokinetic (PBPK) model was used to estimate the concentrations of TCE in the brain achieved during each exposure condition. The F2 amplitude of the VEP decreased monotonically as a function of the estimated peak brain concentration but was not related to the area under the curve (AUC) of the brain TCE concentration. In comparison to estimates from the PBPK model, extrapolations based on Haber's rule yielded approximately a 6-fold error in estimated exposure duration when extrapolating across only a 4-fold change in exposure concentration. These results indicate that the use of a linear form of Haber's rule will not predict accurately the risks of acute exposure to TCE, nor will an estimate of AUC of brain TCE. However, an estimate of the brain TCE concentration at the time of VEP testing predicted the effects of TCE across exposure concentrations and durations.
The exposure conditions under which toxicological data are collected often differ from those of concern for assessing the risks to exposed human populations, requiring extrapolations or adjustments in an attempt to more accurately predict the risks of exposure. Standard practice is to adjust exposure concentrations set for one duration value (e.g., 6 h) to fit other durations (e.g., 24 h) based on the assumption of a linear relationship between exposure concentration and duration. In this example, the exposure concentration might be adjusted by the factor 6/24 to account for the difference in exposure duration. The theoretical basis for this type of adjustment stems from Haber's rule, which states that the product of concentration (C) and duration of exposure (t) produces a constant toxic effect (i.e., C ϫ t ϭ k). A linear concentration-duration adjustment is appropriate if the cumulative total amount of exposure to a compound is the determinant of toxicity. When the linear form of Haber's rule does not accurately describe toxicity across exposure durations, various nonlinear derivatives of Haber's rule have been used to fit empirical data (Atherley, 1985; Jarabek, 1995; Miller, 2000; ten Berge et al., 1986) . In many cases, the empirical data required to derive concentration-duration functions may not be available. In addition, there is a debate regarding the extent to which Haber's rule in any formulation is an appropriate basis for durationbased extrapolations. Atherley (1985) , for example, critically reviewed the literature and concluded that the scientific validity of Haber's rule had not been established and that its use led to the confusion of exposure, such as the concentration of a compound in air, and true dose, the amount of compound absorbed by the organism. More recently, however, Rozman (1999) concluded that Haber's rule reflects a fundamental law of toxicology, provided that the conditions of toxicokinetic steady state and/or irreversibility of effect are met. Risk assessments, however, must often consider conditions of nonsteady-state fluctuations of exposure and reversible deficits.
An alternative approach to formula-based Haber's rule for adjusting exposure concentrations and durations is the consideration of different exposure scenarios on the basis of target tissue concentrations (Andersen et al., 1987; Jarabek, 1995) . The advent of physiologically based pharmacokinetic (PBPK) models has enabled the prediction of target tissue concentrations resulting from a variety of exposure situations (Ramsey and Andersen, 1984) . The issues then become understanding the extent to which tissue concentrations predict toxicity and determining appropriate and predictive measures of tissue dose. An assessment of the published literature for the behavioral effects of acute exposure to toluene found that blood concentrations at the time of testing, estimated using a PBPK model, consistently predicted behavioral deficits across several otherwise diverse experimental reports (Benignus et al., 1998) . Presumably, blood toluene concentration was a good surrogate for the more critical parameter, brain toluene concentration, which was linked to behavioral disruption. It is of interest to further study the relationships between exposure conditions, tissue concentrations, and neurological outcomes in an attempt to better understand the risks of exposure to differing concentrations and/or durations of volatile organic compounds (VOCs).
The exposure scenario is a particularly important consideration for neurological effects of exposure to VOCs, for which effects of acute exposure change quickly over time because of rapid absorption, distribution, and elimination of the compounds. The VOCs are widely used in industrial processes, and trichloroethylene (TCE) is among the leading VOCs in the United States, both in terms of industrial usage and environmental release. In a national air toxics assessment, the US Environmental Protection Agency estimated that 25,700 tons of TCE were emitted into the air in the United States in 1996 (USEPA, 2002a). The Toxics Release Inventory of the EPA cataloged over 10 million pounds of TCE released in 1999 (USEPA 2002b) . There is concern that TCE, or its metabolites, may be carcinogenic (e.g., see reviews by Moore and Harringtion-Brock, 2000, and Wartenberg et al., 2000) . Chronic exposure to TCE has been shown to cause a variety of noncancer health effects, including neurotoxicity (Arlien-Sborg, 1992; ATSDR, 1997) . Neurological effects of chronic or repeated acute TCE exposure include motor (Feldman et al., 1988) , cognitive (Grandjean et al., 1955; Kulig, 1987) , and sensory deficits (Crofton and Zhao, 1993; Crofton et al., 1994; Jaspers et al., 1993; Rebert et al., 1991) . Chronic occupational exposure to a variety of organic solvents or solvent mixtures, in some cases including TCE, has been linked to impaired visual contrast sensitivity or color perception (Broadwell et al., 1995; Frenette et al., 1991; Mergler et al., 1991) . Like many environmental neurotoxicants, the relationships between different TCE exposure scenarios and neurotoxicological outcomes are not well understood. Describing the relationship between exposure scenarios and the resultant effects on neurological function would help to assess the risks of many potential exposure situations, in particular those involving short-term or variable exposure conditions. Previous attempts to link internal concentrations of VOC compounds with neurological or behavioral outcomes have been hampered by a combination of conditions including longlasting behavioral test sessions, during which tissue VOC concentrations can be expected to change markedly. Brain concentrations can be expected to increase during testing if behavioral assessment occurs during exposure or decrease during testing if assessment occurs after exposure. When tissue concentrations differ markedly from the beginning to the end of the behavioral assessment interval, it is difficult to link a measured behavioral change to a value of tissue dose. To overcome these difficulties and to relate the estimates of internal doses of TCE and other VOC compounds more accurately to neurophysiological changes, we constructed a unique exposure and testing apparatus that allowed concurrent head-only inhalation exposure and assessment of visual function. Each assessment of visual function lasted only about 1 min, during which time blood or brain TCE concentrations remained relatively constant.
The current experiments evaluated the acute neurological effects of exposure to TCE as a function of changing exposure concentration and duration. Neurological changes were assessed with an electrophysiological measure of visual function, a type of sensory-evoked potential referred to as pattern-elicited visual-evoked potentials (VEPs), using a unique exposure assessment system suitable for this project. Several types of VEPs have been used to characterize the effects of exposure to potentially neurotoxic compounds (Boyes, 1994; Dyer, 1985; Herr and Boyes, 1995; Mattsson and Albee, 1988; Rebert, 1983) . Pattern-elicited VEPs are related to psychophysical measurements of visual perception (Campbell and Maffei, 1970) and are reported to change in response to several clinical neurological conditions (Boyes, 1993) or neurotoxicological exposures (Boyes, 1992) . Different exposure scenarios were constructed so that the Haber product (C ϫ t) was constant. The null hypothesis was that the exposure conditions with equivalent C ϫ t products would show equal toxic effects. The magnitude of change in VEP amplitude was compared to different measures of TCE dose, including the C ϫ t product; the area under the curve of TCE concentration in the brain estimated by the PBPK model; and the peak, or momentary, brain concentration of TCE at the time VEPs were recorded as estimated by the PBPK model.
MATERIALS AND METHODS
Test compound. The test compound was 1,1,2-trichloroethylene (TCE) (CAS # 79-01-6). The TCE was a spectrophotometric-grade clear liquid, 99.5% pure, according to the supplier (Aldrich Chemical Co., St. Louis, MO).
Test animals. Male Long-Evans rats (LE) (Crl:(LE)BR), approximately 60 days of age, were obtained from Charles River Laboratories (Raleigh, NC). The rats were housed individually in polycarbonate cages with wood-chip bedding, provided ad libitum access to tap water and rat chow (Ralston Purina Co., St. Louis, MO) and allowed to acclimate to the animal colony for at least one week. The animal colony had an ambient temperature and relative humidity of 22 Ϯ 2E C and 50 Ϯ 10%, respectively, and a 12:12 h light:dark cycle (lights on at 6:00 A.M.) with an illumination of approximately 800 lux, measured 1 m above the floor, during the light cycle. All aspects of the care and treatment of the laboratory animals were approved by the institutional laboratory animal care and use committee and were in compliance with applicable federal guidelines for laboratory animal experimentation.
Surgery. The rats were anesthetized (sodium pentobarbital; 50 mg/kg i.p.) and placed in a standard stereotaxic device. Using aseptic surgical conditions, recording electrodes were implanted into the skull, epidurally, in the following locations: 1 mm anterior to lambda and 4 mm left of the midline overlying the primary visual cortex, and 2 mm anterior to bregma and 2 mm lateral left and right to the midline for ground and reference electrodes, respectively. The electrodes were constructed previously from stainless steel screws (00 -90 ϫ 1/16 in) soldered to Nichrome wires. After implantation, the electrode wires were connected to a nine-pin connector (WirePro model 223-1609; Resource Electronics, Raleigh, NC), the assembly was encased in acrylic, and the wound was sutured. Approximately 1 week was allowed for surgical recovery before electrophysiological testing. Details of this preparation have been described in Herr et al. (1992) .
Inhalation exposure. Vapors of TCE were generated with a J-tube-design inhalation system (McGee et al., 1994) , constructed so that either all or a portion of the output could be directed into the chamber. Carbon and HEPAfiltered air was used as the generator sweep gas and introduced into the bottom of the J-tube at a flow rate of 6.6 l/min. The J-tube was heated to 80°C using heat tape. A syringe pump (Model 22; Harvard Apparatus, South Natick, MA) was used to meter TCE into the air stream of the J-tube. A 3-foot length of flexible, finned stainless steel tubing (321-6-x; Cajon Co., Macedonia, OH) was used as a heat exchanger to cool the generator output to room temperature before introduction into the exposure chamber. Exposure atmospheres were monitored online with a long path-length dispersive infrared (IR) spectrophotometer (Miran, 1A; Foxboro Co., East Bridgewater, MA). The exposure monitor system was calibrated using a closed loop system, and TCE levels were confirmed using gas chromatography.
Exposure atmospheres were presented to the test subjects in a head-only exposure chamber as depicted in Figure 1 . The interior dimensions of the head chamber space were 10 ϫ 10 ϫ 17 cm (width ϫ depth ϫ height). The chamber was constructed of stainless steel with the exception of the front and one side wall, which were constructed of glass to allow viewing of the stimulus screen by the rat, and the rat by the experimenter, respectively. The chamber wall facing the experimenter contained a small port, covered with a noninflated balloon, through which the experimenter could gently remove obstructing materials from the rat's right eye with a cotton swab, if necessary, to maintain a clear visual field.
The rats were not anaesthetized for testing. To conduct exposures, the rats were equipped with a rectal thermometer probe and then restrained in a plastic decapicone (Braintree Scientific, Braintree, MA), with portions of the cone cut away to uncover the rat's eyes, nose, and ears. The rats were placed into the exposure chamber, the electrode headset was connected to a cable exiting the chamber, and a gas-tight seal was formed around the rat's upper torso using a latex glove taped to the restrainer and fitted around a ring on the wall of the exposure chamber. The chamber enclosing the rat's body was swept with room air at a high rate (approximately 300 l/min) and kept under negative pressure to prevent fugitive vapors from entering the opened lab space.
Visual stimuli. Visual stimuli were presented on a video monitor (ViewSonic 15, model 1564M; Walnut, CA) located approximately 15 cm from the rat's eyes outside the glass face of the exposure chamber. Visual stimuli were generated with a computer-based system described in detail in Hamm et al. (2000) operated in a "stand-alone" mode. Briefly, video stimulus patterns were provided to the memory of a super-VGA graphics display card operated at 640 ϫ 480 resolution, 256 colors in Video Electronics Standards Association (VESA) mode 101 hexadecimal. The "green" video card output signal was then processed with analog circuitry. Analog multipliers were used to set the contrast, apply the temporal modulation, and set the overall luminance. Sixteen-bit D/A converters were used to generate the percent contrast and luminance control signals. A temperature-regulated diode gamma correction stage was used to help linearize the monitor response curve. The video board was operated at a vertical refresh rate of 72.8 Hz. A separate higher frequency time base (unsynchronized to the vertical refresh clock) was used for sine wave temporal modulation. The visual system provided a synchronization pulse to trigger the data collection system at the beginning of the pattern appearance cycle. Calibration of the brightness and contrast of the display monitor and the video subsystem was accomplished using a separate calibration program and the digitized output of a photometer (EG&G model 450 photometer, model 550-2), a multiprobe with model B1219 photometric filter, or a fiber-optics probe (EG&G model 550-14; Salem, MA). Percent contrast refers to the difference between the light and dark portions of the stimulus pattern, defined as (L max -L min )/(L max ϩ L min ) ϫ 100, with L max and L min reflecting the maximum and minimum luminance portions of the stimulus pattern, respectively. Calibration of the video monitor showed a linear relationship between the input signal voltage and percent contrast up to approximately 80% contrast.
The visual stimulus pattern was a vertical grating with a sinusoidal spatial luminance profile. The mean stimulus luminance was approximately 10 cd/m 2 . The primary stimulus parameters determining the response to visual pattern modulation are spatial frequency and contrast. Spatial frequency refers to the size of the visual pattern and is expressed as the number of stimulus cycles/ degree visual angle (cpd). Pilot experiments indicated that the effects of acute TCE inhalation on VEP amplitudes were independent of the spatial frequency FIG. 1. Schematic of the inhalation device. Awake, restrained rats were placed in a head-only exposure chamber that had a glass face to enable viewing of the visual stimuli during inhalation exposure. Vapors of TCE were generated with a J-tube-design inhalation system, and exposure concentrations were monitored online during experimental sessions with an infrared (IR) spectrophotometer.
or contrast of the stimulus pattern, and therefore a single stimulus pattern was selected for the current experiment. The stimulus employed had a spatial frequency of 0.16 cpd and a visual contrast of 60%. A value of 0.16 cpd was selected because it fell near the peak of the contrast sensitivity function of the pigmented rat. A value of 60% contrast was selected because it fell well within the linear portion of the video monitor response function and yet yielded a strong evoked potential. The stimulus was temporally modulated in an on-off fashion with a 5-Hz sinusoid.
Evoked potential recording. The electrophysiological potentials were amplified, bandpass-filtered (1-100 Hz; roll off ϭ 12 dB/octave), and sampled in 1-s epochs (512 data points per epoch) using a Pathfinder II signal averager (Nicolet Biomedical, Madison, WI), so that each sample epoch contained five cycles of the stimulus temporal modulation. Averaged evoked potentials were constructed from 50 epochs and then submitted to spectral analysis (SPECTM Program; Nicolet Biomedical, Madison, WI). The spectral amplitude at the stimulus rate (F1) and twice that rate (F2) were recorded as dependent variables.
Experimental design. The rats (n ϭ 9 or 10/group) were exposed to either clean air or trichloroethylene (TCE) under one of four exposure conditions designed to have a constant C ϫ t product of 4000 ppm-h. The exposure scenarios were either 0 ppm for 4 h, 1000 ppm for 4 h, 2000 ppm for 2 h, 3000 ppm for 1.3 h, or 4000 ppm for 1 h. The VEPs were recorded during the last minute of exposure. A single test duration was selected for the group exposed to the control air to avoid the necessity of four separate control groups. The test duration of 4 h was selected for the control group because we have occasionally observed a slight reduction in VEP amplitude over the course of several h recording, perhaps related to cumulative fatigue or stress due to the necessary restraint for head-only exposure and recording. By maximizing the test duration and amplitude decline of the control group, we were introducing a bias-if any-in the direction away from being able to detect VEP amplitude reductions caused by exposure to the test compound. With regard to comparing the dose groups to one another, a bias, if any, caused by the different exposure durations would tend to favor maximizing the amplitude reductions in the longer duration (lower TCE concentration) groups relative to those groups with shorter durations and higher concentrations.
Statistical analysis. The two dependent variables, the amplitudes of the F1 and F2 spectral components, were analyzed using a multivariate analysis of variance available in PROC GLM of SAS (1989) . The independent variable was the dose or treatment group; a between-subjects factor with five levels. Statistical significance was defined as 0.05 divided by the number of dependent variables, or 0.05/2 ϭ 0.025. For dependent variables demonstrating a statistically significant effect of treatment, univariate contrasts between the individual dose groups were examined using a value of p Ͻ 0.05 as the criterion of significant difference. Body temperature data were examined as a control procedure using an analysis of variance, because body temperature changes can complicate the interpretation of electrophysiological data. Body temperature changes, however, were not considered to be a part of the formal hypothesis testing.
Tissue TCE concentrations. To determine the tissue concentrations of TCE under a variety of exposure conditions, the rats were exposed by inhalation to 200, 2000, or 4000 ppm of TCE for durations of 5, 20, or 60 min. In addition, some rats were exposed to TCE at the above concentrations for 60 min and then clean air for 60 min to evaluate clearance of the compound. The procedures for exposing the rats to TCE vapors in dynamic flow-through chambers, for rapidly removing tissues from the experimental animals, and for analysis of the tissues for TCE concentration using gas chromatography with electron capture detection were described in Simmons, et al. (2002) . The primary data from these experiments were also presented in Simmons et al. (2002) in association with evaluating the performance of the PBPK model used here. In the present paper, an additional analysis of these data is presented examining the relationship between simultaneous concentrations of TCE in the blood and brain. PBPK model. A five-compartment (brain, liver, fat, slowly perfused, and rapidly perfused) PBPK model developed for TCE in the LE rat (Simmons et al., 2002) was used to estimate the concentration of TCE in the brain under different exposure conditions. Values were derived for the volumes of the liver, brain, and fat compartments from measurements made in LE rats. Partition coefficients were measured in tissue homogenates from LE rats by the vial equilibration methodology described by Gargas et al. (1989) . LE rats were exposed individually to TCE in a closed-uptake vapor chamber with O 2 supplied as needed and CO 2 removed. The model was used to estimate the metabolic rate constants V max and K m by optimization with Simusolv (Version 3.0, 1993) to obtain the best fit to chamber concentrations curves. Simulations were performed with this model to estimate the brain, blood, liver, and fat concentrations of TCE during and after constant-concentration inhalation exposures. These model simulations provided a reasonable fit to experimentally measured brain, blood, liver, and fat concentrations of TCE obtained from rats exposed by inhalation in flow-through chambers to TCE. A full description of the model, along with the experimental data used to evaluate model performance, is presented in Simmons et al. (2002) . Estimated values derived from the PBPK model for comparisons to VEP outcome measures included the brain concentrations at the moment of VEP recording and the area under the brain concentration curve (AUC) measured from the onset of exposure to the moment of VEP recording.
RESULTS
All of the rats remained awake and kept their eyes open during testing. The rats exposed to higher concentrations of TCE appeared to be slightly sedated upon removal from the test chamber, although awake and mobile. There was no apparent effect of TCE treatment on the body temperature recorded at the time of VEP testing (0 ppm/4 h: 37.5 Ϯ 0.16; 1000 ppm/4 h: 37.5 Ϯ 0.24; 2000 ppm/2 h: 37.1 Ϯ 0.27; 3000 ppm/1.3 h: 37.0 Ϯ 0.14; and 4000 ppm/1 h: 37.3 Ϯ 0.18 (mean Ϯ SEM in EC)), which was confirmed by the statistical analysis demonstrating no effect of TCE treatment on body temperature (F(4,43) ϭ 1.24, p ϭ 0.31).
Brain concentrations of TCE estimated from the PBPK model for the different exposure scenarios are presented in Figure 2 . Two values from each curve were examined for the ability to predict evoked potential deficits, including (1) the area under the curve and (2) the momentary value obtained at the time of VEP testing. Among the exposure groups, estimated values of AUC were higher at the longer exposure durations (e.g.,1000 ppm ϫ 4 h) whereas estimated values of momentary concentration were higher at the higher air concentrations of TCE (e.g., 4000 ppm ϫ 1 h), as shown in Figure 2 .
Tissue concentrations of TCE in the blood and brain samples of the exposed rats show a close linear relationship between the two measures, with a slope value of approximately 1 (Fig. 3) . figure) is a group-average composite constructed from all of the rats in the treatment group to illustrate group trends. Groupmean waveforms are averaged point-by-point across rats and therefore can underestimate the mean of the individual ampli-tude values if there are individual differences in the phase of response. Nevertheless, group-mean waveforms are useful to illustrate group trends. Each panel on the right side of the figure presents the group average of the individual subject amplitude spectrum derived from the waveform shown immediately to its left. In the group-average waveform of the control group (0 ppm ϫ 4 h) the predominant component of the steady-state response is a frequency-double component labeled F2 occurring at approximately 10 Hz. This finding is consistent with other studies of pattern-elicited steady-state potentials recorded from rats using similar visual stimulus parameters (Boyes, 1994; Moser and Boyes, 1993) . A smaller, but more variable, frequency-single component (F1) is also occasionally evident. The statistical analysis of F1 amplitude showed no significant main effects of TCE treatment (F(4,43) ϭ 0.23, p ϭ 0.92).
As the TCE concentration increased, the amplitude of the VEP F2 component decreased. This was evident in both the group-average waveforms and in the averaged spectral analysis presented in Figure 4 . The decline of the frequency double component with TCE treatment apparent in the group average waveforms (Fig. 4) was also observed in the mean of the F2 amplitudes of the individual rats, as shown in Figure 5 . The left panel of Figure 5 shows the F2 amplitude (mean Ϯ SEM) plotted as a function of TCE atmospheric exposure expressed as the concentration-duration (C ϫ t) product. The statistical analysis of the F2 amplitude data showed a significant main effect of treatment (F(4,43) ϭ 5.15, p ϭ 0.0018). The individual group contrasts indicated that the control group (0 ppm/4h) was significantly different from all of the others, and the groups exposed to 1000 ppm/4h and 2000 ppm/2h were each significantly different from the group exposed to 4000 ppm/1h (all F(1,43) Ͼ 4.2, all p Ͻ 0.05). These results demonstrate that the postulate of Haber's rule, that all of the dose groups with the same C ϫ t product would produce the same toxic effect, did not hold true in this case.
The amplitude of the F2 component also was examined as a function of two measures of internal TCE dose, the AUC and the momentary brain concentration of TCE at the time of testing. When the F2 amplitude was plotted as a function of brain AUC (Fig. 5B) , the amplitude was not monotonically related to the TCE concentration. In contrast, a monotonically decreasing relationship was obtained when the F2 amplitude was plotted against the brain TCE concentration at the time of VEP assessment (Fig. 5C) .
It was of interest to evaluate the differences between exposure duration extrapolations based on Haber's rule and those based on equivalent target tissue concentrations as predicted by the PBPK model. To do this, a point of departure of 25-mg/l TCE in brain tissue was selected from Figure 5C . This value was selected for illustrative purposes only, as being halfway between the lowest dose given, which was significantly different from clean air controls, and the control value. The exposure durations predicted to give rise to a brain concentration of 25 mg/l following exposure to 1000, 2000, 3000, or 4000 ppm were then determined from the PBPK model and are plotted as the data points in Figure 6 . Next, a line depicting Haber's rule extrapolation according the formula C ϫ t ϭ K was fit to the 25-mg/l point for 4000 ppm exposure (diagonal dashed line in Fig. 6 ). Finally, a horizontal and two vertical lines were added to illustrate the differences between extrapolation along either the Haber's rule functions and the predictions of effects based on equal brain concentrations of 25 mg/l. When using Haber's rule to extrapolate from 4000 ppm to 1000 ppm, Haber's rule predicts that at 1000 ppm an exposure duration of approximately 0.14 h would produce the same effect, whereas the PBPK model indicates that an exposure duration of 0.875 h would be required to reach the same brain concentration. Thus, in this example, when Haber's rule was used to predict across a 4-fold difference in exposure concentration, the result was over a 6-fold error in exposure duration.
DISCUSSION
The amplitude of pattern-elicited visual-evoked potentials in rats treated with TCE vapors decreased with increasing atmospheric TCE concentrations. The four dose groups with equal C -t product exposure conditions did not have equal deficits in VEP amplitude, in contrast to the prediction by Haber's rule of a constant toxic effect. If a linear interpretation of Haber's rule were correct, then all four treatments should have produced the same effect on the F2 amplitude, since all four treatments had the same C ϫ t product of 4000 ppm/h. This was not the case, however, as the F2 amplitude reduction was greater with increasing air TCE concentration. When the brain TCE concentrations were predicted with a PBPK model, the brain concentration at the time of VEP assessment, but not the area 
FIG. 4.
Group average VEP waveforms recorded during exposure to TCE (n ϭ 9 -10/group). (Left) Visual evoked potentials following 5-Hz modulation of the visual pattern, which were averaged across each animal in each treatment group. (Right) Spectral analysis of each individual rat waveform, which was then averaged across the group. Spectral amplitudes at the stimulus rate of approximately 5 Hz (F1) and the second harmonic frequency at approximately 10 Hz (F2) are labeled. Exposure to TCE reduced the F2 amplitude for all exposure conditions. At 4000 ppm ϫ1 h, the response shifted from being predominately frequency double to frequency single in character.
under the curve, predicted the magnitude of the evoked potential amplitude deficit across different exposure conditions.
The current finding that a traditional linear expression of Haber's rule (i.e., C ϫ t ϭ k) was inadequate to predict toxicity across exposure durations is consistent with the other neurotoxicological outcomes examined following inhalation exposure to TCE. This study adds to evidence regarding the neurotoxicological effects of TCE over changing exposure conditions (Boyes et al., 2000) . Crofton and Zhao (1997) examined hearing loss in LE rats following exposure to TCE concentrations ranging from 800 to 8000 ppm and exposure durations ranging from 1 day (6 h) to 13 weeks (6 h/day, 5 days/week). Bushnell (1997) examined deficits in signal detection behavior in LE rats during exposure to TCE concentrations ranging from 400 to 2400 ppm and durations ranging from 20 to 60 min. In both cases, default extrapolations across exposure durations based on Haber's rule lead to incorrect estimates of the minimally toxic concentration, with the direction of the error dependent on the direction of the extrapolation. Extrapolation by Haber's rule from shorter to longer duration exposures resulted in overestimates of risk. In the opposite case, the use of Haber's rule to extrapolate from longer to shorter duration exposures resulted in the underestimation of risk (Boyes et al., 2000) . Rozman (1999) contends that Haber's rule holds under conditions of toxicokinetic steady state and/or irreversible damage. Neither of those conditions hold for the acute reversible effects of TCE such as examined here or reported by Bushnell (1997) . Haber's rule did not hold for the irreversible hearing loss caused by repeated exposure to TCE (Crofton and Zhao, 1997) or for the peripheral neuropathy caused by exposure to acrylamide (Crofton et al., 1996) . These examples illustrate that a criterion of irreversible effects must exclude factors such as tolerance or repair for application of Haber's rule. Clearly, other means of extrapolation of toxic effects across exposure durations are needed to predict and assess the risks of untested exposure scenarios where condi-
FIG. 5. (A)
Evoked potential F2 amplitude as a function of inhalation exposure concentration-duration (C ϫ t) product. A statistically significant reduction in the F2 amplitude was produced by each exposure condition in comparison to the air control group (0 ppm/4 h). The groups exposed to 1000 ppm/4 h and 2000 ppm/2 h were significantly different from the group exposed to 4000 ppm/1 h, as described in the text. All of the groups receiving TCE had a C ϫ t product of 4000 ppm/h; the plotted points are slightly displaced horizontally to improve visibility. (B) Evoked potential F2 amplitude plotted as a function of estimated TCE concentration in the brain expressed as area under the curve. The TCE area under the curve values were estimated using the PBPK model, as depicted in Figure 2 . Evoked potential F2 amplitude reduction was not related to the area under the curve. (C) Evoked potential F2 amplitude plotted as a function of estimated TCE concentration in the brain, expressed as the estimated concentration at the moment of VEP assessment. The TCE brain concentrations were estimated using the PBPK model, as depicted in Figure 2 . The evoked potential F2 amplitude was reduced as a function of the simultaneous TCE concentration in the brain.
tions of toxicokinetic steady state or permanent damage are not met.
Although many risk assessors are aware that there may be errors in extrapolation when using Haber's rule, there is a general belief that the errors introduced are minor in comparison to other uncertainties in typical risk assessments. The illustrative analysis presented here in Figure 6 shows that the magnitude of error possible when using Haber's rule can be substantial. A greater then 6-fold error in duration estimation was introduced when extrapolating over only a 4-fold change in concentration. Obviously, the magnitude of the error of estimation will increase with increases in the extrapolation range, since the Haber's and PBPK functions diverge from a common point. In any application, the magnitude of error introduced by use of Haber's rule will be a function of many factors, including the difference in slope between Haber's rule and the "true" function and the extent of the extrapolation interval. When extrapolating from short-to long-duration exposures, Haber's rule was overprotective in that the predicted exposure interval underestimated the point of equal tissue dose. If the extrapolation were to be conducted in the direction from long to short durations, Haber's rule could have predicted "safety" at exposure durations associated with toxic brain concentrations. The underprotective nature of Haber's rule when extrapolating from long-to short-duration exposures is generally known among risk assessors, and therefore Haber's rule is typically not used for this purpose. Our results illustrate the potential magnitude of such errors. Different exposure scenarios result in different toxicities because the target tissue doses achieved are not equal. It follows that a better way to predict toxicity for different exposure situations is to understand the target tissue concentrations achieved for each exposure situation and the relationships between target tissue concentrations and the expression of toxicity. Andersen and co-workers (1987) proposed that PBPK models be used to predict target tissue dose and that this approach form the basis of extrapolations across exposure durations. They argued that, in most cases, toxicity would be related to an integrated measure of tissue dose, such as the area under the curve, but peak concentration would be an appropriate measure for situations such as a reversible interaction of the compound with a tissue protein with rapid clearance of the compound and no residual damage. The area under the curve can be considered an equivalent measure of Haber's C ϫ t product, only based on absorbed dose rather than exposure. It is interesting that, even when based on absorbed dose, the integrated dose measure did not describe the change in toxicity across exposure scenarios. Rozman (1999) concluded that if the toxicokinetic half-life of a compound is longer than its toxicodynamic half-life, then the toxicokinetics will be ratedetermining. In the case here, TCE can be assumed to have a rapid and reversible interaction with the neural tissue and therefore to fit the case where the toxicokinetics is rate-determining. In a review of the published literature of the acute behavioral effects of exposure to toluene in rat and human subjects, Benignus et al. (1998) found that plotting the outcomes of several studies as a function of peak toluene level in blood estimated from a PBPK model yielded consistent doseeffect curves across a variety of different laboratories. Thus, for the two organic solvents TCE and toluene, the appropriate measure of tissue dose for describing the acute neurological effects appears to be the tissue concentration at the moment of testing.
Some of the data in this manuscript were included in a previous summary report of the EPA's evaluation of the scientific basis for reassessment of TCE risks (Boyes et al., 2000) . The previous report compared VEP outcomes to blood TCE concentrations estimated from a preliminary version of the PBPK model. The current analysis employed a revised version of the PBPK model that included a separate brain tissue compartment not previously available (Simmons et al., 2002) . The brain is presumably the relevant target tissue for VEP outcomes, and the current PBPK model predicts sampled brain concentrations better than it does blood concentrations. We have also demonstrated a relationship between blood and brain TCE concentrations. Finally, we present an example of a duration adjustment that might be used in risk assessment to
6. An illustration of the discrepancy between estimates of equivalent exposure durations based on Haber's rule and those based on equivalent brain concentrations estimated from the PBPK model The plotted points represent PBPK model estimates of exposure durations resulting in a brain TCE concentration of 25 mg/l following exposure to 4000, 3000, 2000, or 1000 ppm from left to right, respectively. A dashed diagonal line represents an extrapolation originating from the 4000 ppm point based on Haber's rule (C ϫ t ϭ K). The horizontal line represents 1000 ppm. The two vertical lines illustrate the difference between the Haber's rule extrapolations to 1000 ppm, (line to the left) and the duration estimated from the PBPK model to reach the equivalent brain concentration (line to the right). Using Haber's rule to extrapolate from the 4000 ppm point to predict an equivalent exposure duration at 1000 ppm value yields an estimated duration of 0.14 h. In comparison, the PBPK model indicates that, at 1000 ppm, a brain concentration of 25 mg/l will not be reached until an exposure duration of 0.875 h, a difference in estimation of over 6-fold. compare the results using an approach based on Haber's rule with one based on maintaining equivalent tissue dose levels.
In consideration of the proper metric of tissue dose, it is important to determine if the effects are caused by the parent compound or by one or more of its metabolites. Among the metabolites of TCE, chloral hydrate is a known sedativehypnotic and trichloroethanol is likely the active metabolite of chloral hydrate (Krasowski et al., 1998; Peoples and Weight, 1998; Rall, 1990 ). The PBPK model indicated that TCE metabolism becomes saturated at atmospheric concentrations above about 400 ppm. The fact that a dose-response relationship was observed at concentrations above metabolic saturation suggests that the effects observed here were attributable primarily to the parent compound.
Sensory-evoked potentials, as recorded here with a large extradural electrode, reflect the combined activity of a large number of visual cortex neurons firing in response to the patterned visual stimulus. The relationship between a multicellular recording like the VEP as recorded here and the activity of individual visual neurons cannot be known with certainty, but there are features of prominent visual cell types that resemble the activity observed in pattern appearance/disappearance VEPs. Individual retinal ganglion cells have characteristic "linear" or "nonlinear" temporal response profiles. Linear cells respond primarily at the stimulation rate (F1) for stimuli that are sinusoidally modulated in time (Davson, 1990; Lennie and Perry, 1981; So and Shapley, 1979) . Nonlinear cells, in contrast, show more complex temporal response profiles with activity at both F1 and F2. In both rats and humans, the pattern appearance/disappearance VEP F1 component shows a bandpass-spatial frequency profile (Hudnell and Boyes, 1991) similar to the F1 response of linear retinal ganglion cells. The VEP F2 response shows a low-pass spatial frequency profile (Hudnell and Boyes, 1991) similar to the F2 response of nonlinear retinal ganglion cells. The temporal response profiles of the retinal ganglion cells are passed on to cells in the lateral geniculate nucleus and then to the visual cortex. In the cortex, the cells maintain linear and nonlinear temporal response characteristics, although the set of response profiles becomes more complex than at earlier stages of the visual pathway. The similarities in spatial/temporal response profiles makes it reasonable to presume that the VEP F1 component arises from the summed activity of the linear visual cells, and VEP F2 arises from the summed activity of the nonlinear visual cells, originally encoded in the retina and preserved along the visual projections to be recorded at the visual cortex.
In summary, these data indicate that (1) acute inhalation of TCE can alter visual function in rats and (2) a linear application of Haber's rule to the data does not accurately describe the change in toxicity across different exposure durations, but (3) the magnitude of the effects could be accurately predicted by the brain TCE concentration at the time of visual function evaluation. The results suggest that risk assessment decisions requiring the extrapolation of effects across exposure durations would more accurately reflect risk if they were based on the determination of the equivalent target tissue concentrations than if based on the assumptions of Haber's rule.
